Transformative therapies with high up-front costs will exacerbate the need to address gaps between payers when costs and benefits occur at different times.
Noam Kirson, PhD
Advertisement
Articles by Noam Kirson, PhD
Advertisement
Latest Updated Articles
- Insurance Switching and Mismatch Between the Costs and Benefits of New Technologies
Published: December 13th 2017 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
3
How Medicaid Reforms Could Deepen State Coverage Gaps
4
Flow Cytometry Tool Could Improve Treatment Monitoring in MS
5
